Has Douglas Edgren, MD received payments from drug or device companies?

Yes. Drug and device makers reported $5,003 in general payments to Douglas Edgren, MD across 283 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Douglas Edgren, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Douglas Edgren, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Douglas Edgren, MD

Family Medicine · Cheyenne, WYNPI 1033145164

Payments from drug & device makers

$5,003in general payments, 2019–2025

Across 283 payments — averaging $17.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$713
GSK$527
Boehringer Ingelheim$408
Amgen$398
Vanda Pharmaceuticals Inc.$368
AstraZeneca$303
plus $2K from 40 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	44	$713
GSK	31	$527
Boehringer Ingelheim	26	$408
Amgen	24	$398
Vanda Pharmaceuticals Inc.	14	$368
AstraZeneca	15	$303
Novo Nordisk	12	$221
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	13	$186
Merck	10	$154
Exact Sciences	7	$128
Pfizer	6	$117
Lilly USA, LLC	7	$106
Takeda Pharmaceuticals U.S.A., Inc.	5	$101
Novartis	5	$98
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	5	$89
Corium, LLC	5	$80
Biodelivery Sciences International, Inc.	2	$69
Jazz Pharmaceuticals Inc.	4	$65
Harmony Biosciences LLC	2	$57
Biohaven Pharmaceuticals, Inc.	3	$55
Daiichi Sankyo Inc.	3	$52
Boston Scientific	2	$48
Sanofi Pasteur Inc.	3	$46
Nestle Healthcare Nutrition Inc.	3	$45
Astellas Pharma US Inc	3	$44
Ultragenyx Pharmaceutical Inc.	2	$38
Shield Therapeutics Inc	1	$36
Lundbeck LLC	2	$34
Inari Medical, Inc.	1	$34
Viiv Healthcare Company	2	$32
Johnson & Johnson	2	$29
Biogen	2	$28
Amarin Pharma, Inc.	2	$28
Eisai Inc.	2	$28
Inspire Medical Systems, Inc.	1	$26
Melinta Therapeutics, LLC	2	$26
Kyowa Kirin, Inc.	1	$25
Abbott	1	$24
Supernus Pharmaceuticals, Inc.	1	$22
Edwards Lifesciences	1	$22
Sanofi-aventis U.S. LLC	1	$19
Upsher-smith Laboratories LLC	1	$18
Optinose US, Inc.	1	$17
Teva Pharmaceuticals USA, Inc.	1	$16
Medtronic	1	$13
Kaleo, Inc.	1	$11

How this compares

$5,003 in reported general payments places this provider in the 95th percentile of 237 family medicine providers in Wyoming.

See all family medicine providers in Wyoming →

Medicare billing

Part B allowed, 2024

$320,951

Medicare patients

898

Services billed

13,465

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Cheyenne

John BabsonCheyenne$114K
Jonathon MedinaCheyenne$6K
Carol FischerCheyenne$6K
Nancy BergquistCheyenne$3K
Amy HarnishCheyenne$2K
Joseph DobsonCheyenne$2K
Gregory StampfliCheyenne$2K
Samuel HartCheyenne$2K
Aaron FreemanCheyenne$2K
Patrick YostCheyenne$1K

See the full list for Wyoming →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →